期刊文献+

过氧化物酶体增殖剂活化受体与心肌重塑 被引量:1

Peroxisome Proliferator-activated Receptors and Heart Remodeling
下载PDF
导出
摘要 过氧化物酶体增殖剂活化受体是一类核转录因子 ,具有多种有益的生理作用 :参与心脏能量代谢 ,增加胰岛素敏感性 ,阻断过度激活的肾素 血管紧张素系统和胰岛素抵抗形成的恶性循环 ,抑制炎症反应 ,改善心功能 ,提高血管顺应性、降低后负荷 ,对抗心肌重塑。缺血 /再灌注时过氧化物酶体增殖剂活化受体激动剂抑制心肌组织炎症细胞浸润 ,减轻心肌缺血 /再灌注损伤而保护心脏。 Peroxisome proliferator-activated receptors (PPASs),transcription factors belonging to the nuclear receptors family,play a critical role in the pathophysiology of cardiac remodeling.PPASs manipulate cardiac energy metabolism,downregulate inflammatory response,improve insulin resistance to break vicious cycle formed by overactivated rennin-angiotensin system(RAS) and insulin resistance,decrease peripheral vascular resistance to reduce afterload.PPASs agonists also reduce myocardial injury and dysfunction caused by ischemia/reperfusion.
作者 汪华玲 覃数
出处 《心血管病学进展》 CAS 2005年第1期75-77,共3页 Advances in Cardiovascular Diseases
关键词 增殖 心肌重塑 受体 过氧化物酶体 心脏 肾素 后负荷 能量代谢 生理作用 保护 Peroxisome proliferator-activated receptors Cardiac remodeling Insulin resistance Inflammatory response
  • 相关文献

参考文献25

  • 1Vamecq J,Latruffe N.Medical significance of peroxisome proliferator-activated receptors [J].Lancet,1999,354(9173):141-148.
  • 2Ghazzi MN,Perez JE,Antonucci TK,et al.Cardiac and glycemic benefits of troglitazone treatment in NIDDM[J].Diabetes,1997,46(3):433-439.
  • 3Shimoyama M,Ogino K,Tanaka Y,et al.Hemodynamic basis for the acute cardiac effects of troglitazone in isolated perfused rat hearts[J].Diabetes,1999,48(3):609-615.
  • 4Asakawa M,Takano H,Nagai T,et al.Peroxisome proliferator-activated receptor γ plays a critical role in inhibition of hypertrophy in vitro and in vivo[J].Circulation,2002,105(10):1240-1246.
  • 5Iglarz M,Touyz RM,Viel EC,et al.Peroxisome proliferator-activated receptor α and receptor-γ activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension[J].Hypertension,2003,42(4):737-743.
  • 6Yamamoto K,Ohki R,Lee RT,et al .Peroxisome proliferator-activated receptors γ activators inhibit cardiac hypertrophy in cardiac myocytes [J].Circulation,2001,104(14):1670-1675.
  • 7Liang F,Wang D,Zhang S,et al.Peroxisome proliferator activated receptor(PPAR) α agonists inhibit hypertrophy of neonatal rat cardiac myocytes [J].Endocrinology,2003,144(9):4187-4194.
  • 8Lee,SST.Targeted disruption of the [alpha] isoform of the peroxisome proliferator-activated receptor geng in mice results in abolishment of the pleiotropic effects of peroxisome proliferators[J].Mol Cell Biol,1995,15(6):3012-3022.
  • 9Aoyama T.Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor [alpha](PPAR[alpha])[J].J Biol Chem,1998,273(10):5679-5684.
  • 10Chiu HC .A novel mouse model of lipotoxic cardiomyopathy [J].J Clin Invest,2001,107(7):813-822.

同被引文献40

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部